Efficacy of nutritional supplementation with omega-3 and omega-6 fatty acids in dry eye syndrome: a systematic review of randomized clinical trials

Acta Ophthalmologica

Volumn 95, Issue 8, 2017, Pages e677-e685

  Molina Leyva, Ignacio ^a   Molina Leyva, Alejandro ^b,c   Bueno Cavanillas, Aurora ^b  

^a Granada Hospital Complex   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c HOSPITAL TORRECÁRDENAS   (Spain)

Author keywords

clinical trials; dry eye; omega fatty acids; oral supplementation; systematic review

Indexed keywords

ARTIFICIAL TEAR; DOCOSAHEXAENOIC ACID; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ARTICLE; ASSESSMENT OF HUMANS; DEMOGRAPHY; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG EFFICACY; DRY EYE; DRY EYE SEVERITY SCORE; EVIDENCE BASED MEDICINE; FOLLOW UP; GASTRIC INTOLERANCE; GASTROINTESTINAL SYMPTOM; HUMAN; LACTOSE INTOLERANCE; MEDICATION COMPLIANCE; MEIBOMIAN GLAND DYSFUNCTION; MISCELLANEOUS NAMED GROUPS; NONHUMAN; OBJECTIVE IMPROVEMENT; OCULAR SURFACE DISEASE INDEX; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RHEUMATIC DISEASE; SCHIRMER TEST; SEX RATIO; SUBJECTIVE IMPROVEMENT; SYSTEMATIC REVIEW; TEAR BREAK UP TIME; TREATMENT OUTCOME; VISUAL DISPLAY TERMINAL USER; VISUAL SYSTEM PARAMETERS; DIET THERAPY; DIETARY SUPPLEMENT;

DIETARY SUPPLEMENTS; DRY EYE SYNDROMES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 85016773334     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.13428     Document Type: Article

References (44)

1. Ahn JM, Lee SH, Rim TH, Park RJ, Yang HS, Kim TI, Yoon KC & Seo KY (2014): Prevalence of and risk factors associated with dry eye: the Korea National Health and Nutrition Examination Survey 2010-2011. Am J Ophthalmol 158: 1205–1214.
2. Andrade AS, Salomon TB, Behling CS, Mahl CD, Hackenhaar FS, Putti J & Benfato MS (2014): Alpha-lipoic acid restores tear production in an animal model of dry eye. Exp Eye Res 120: 1–9.
3. Argiles M, Cardona G, Perez-Cabre E & Rodriguez M (2015): Blink Rate and Incomplete Blinks in Six Different Controlled Hard-Copy and Electronic Reading Conditions. Invest Ophthalmol Vis Sci 56: 6679–6685.
4. Bhargava R & Kumar P (2015): Oral omega-3 Fatty Acid treatment for dry eye in contact lens wearers. Cornea 34: 413–420.
5. Bhargava R, Kumar P, Kumar M, Mehra N & Mishra A (2013): A randomized controlled trial of omega-3 fatty acids in dry eye syndrome. International journal of ophthalmology 6: 811–816.
6. Bhargava R, Kumar P & Arora Y (2015a): Short-Term Omega 3 Fatty Acids Treatment for Dry Eye in Young and Middle-Aged Visual Display Terminal Users. Eye & Contact Lens 42: 231–236.
7. Bhargava R, Kumar P, Phogat H, Kaur A & Kumar M (2015b): Oral omega-3 fatty acids treatment in computer vision syndrome related dry eye. Contact Lens & Anterior Eye: The Journal of the British Contact Lens Association 38: 206–210.
8. Brignole-Baudouin F, Baudouin C, Aragona et al. (2011): A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients. Acta Ophthalmol 89: e591–e597.
9. Calder PC & Grimble RF (2002): Polyunsaturated fatty acids, inflammation and immunity. Eur J Clin Nutr 56(Suppl 3): S14–S19.
10. Creuzot C, Passemard M, Viau S, Joffre C, Pouliquen P, Elena PP, Bron A & Brignole F (2006): [Improvement of dry eye symptoms with polyunsaturated fatty acids]. Journal francais d'ophtalmologie 29: 868–873.
11. Creuzot-Garcher C, Baudouin C, Labetoulle et al. (2011): Efficacy assessment of Nutrilarm(R), a per os omega-3 and omega-6 polyunsaturated essential fatty acid dietary formulation versus placebo in patients with bilateral treated moderate dry eye syndrome. Journal francais d'ophtalmologie 34: 448–455.
12. Higgins JPT & Green S (2011): Cochrane handbook for systematic reviews of interventions version 5.1.0. London: The Cochrane Collaboration.
13. Huth PJ, Fulgoni VL 3rd & Larson BT (2015): A Systematic Review of High-Oleic Vegetable Oil Substitutions for Other Fats and Oils on Cardiovascular Disease Risk Factors: Implications for Novel High-Oleic Soybean Oils. Advances in nutrition (Bethesda, Md) 6: 674–693.
14. Jackson MA, Burrell K, Gaddie IB & Richardson SD (2011): Efficacy of a new prescription-only medical food supplement in alleviating signs and symptoms of dry eye, with or without concomitant cyclosporine A. Clinical Ophthalmology 5: 1201–1206.
15. Kangari H, Eftekhari MH, Sardari S, Hashemi H, Salamzadeh J, Ghassemi-Broumand M & Khabazkhoob M (2013): Short-term consumption of oral omega-3 and dry eye syndrome. Ophthalmology 120: 2191–2196.
16. Kawakita T, Kawabata F, Tsuji T, Kawashima M, Shimmura S & Tsubota K (2013): Effects of dietary supplementation with fish oil on dry eye syndrome subjects: randomized controlled trial. Biomedical research (Tokyo, Japan) 34: 215–220.
17. Kokke KH, Morris JA & Lawrenson JG. Oral omega-6 essential fatty acid treatment in contact lens associated dry eye. Contact lens & anterior eye [Internet]. 2008; 31(3):141–146; quiz 70 pp.
18. Kremer JM (2000): n-3 fatty acid supplements in rheumatoid arthritis. The American journal of clinical nutrition 71: 349s–351s.
19. Lam H, Bleiden L, dePaiva CS, Farley W, Stern ME & Pflugfelder SC (2009): Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol 147: 198–205. e1.
20. Larmo PS, Järvinen RL, Setälä NL, Yang B, Viitanen MH, Engblom JR, Tahvonen RL & Kallio HP, (2010): Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye. Journal of nutrition [Internet] 140(8):1462–1468.
21. Li J, Zheng K, Deng Z, Zheng J, Ma H, Sun L & Chen W (2015): Prevalence and risk factors of dry eye disease among a hospital-based population in southeast China. Eye & contact lens 41: 44–50.
22. Liu Y, Kam WR & Sullivan DA (2016): Influence of Omega 3 and 6 Fatty Acids on Human Meibomian Gland Epithelial Cells. Cornea 35: 1122–1126.
23. Luo L, Li DQ, Corrales RM & Pflugfelder SC (2005): Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye & contact lens 31: 186–193.
24. Macsai MS (2008): The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). Trans Am Ophthalmol Soc 106: 336–356.
25. Malet F, Le Goff M, Colin J, et al. (2014): Dry eye disease in French elderly subjects: the Alienor Study. Acta Ophthalmol 92: e429–e436.
26. Miljanovic B, Trivedi KA, Dana MR, Gilbard JP, Buring JE & Schaumberg DA (2005): Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. The American journal of clinical nutrition 82: 887–893.
27. Oleñik A, Jimenez-Alfaro I, Alejandre-Alba N & Mahillo-Fernandez I (2013): A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction. Clin Interv Aging 8: 1133–1138.
28. Ong NH, Purcell TL, Roch-Levecq AC, Wang D, Isidro MA, Bottos KM, Heichel CW & Schanzlin DJ (2013): Epithelial healing and visual outcomes of patients using omega-3 oral nutritional supplements before and after photorefractive keratectomy: A pilot study. Cornea 32: 761–765.
29. Paulsen AJ, Cruickshanks KJ, Fischer ME, Huang GH, Klein BE, Klein R & Dalton DS (2014): Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol 157: 799–806.
30. Pinheiro MN Jr, dos Santos PM, dos Santos RC, Barros Jde N, Passos LF & Cardoso Neto J (2007): [Oral flaxseed oil (Linum usitatissimum) in the treatment for dry-eye Sjogren's syndrome patients]. Arq Bras Oftalmol 70: 649–655.
31. Ranasinghe P, Wathurapatha WS, Perera YS, Lamabadusuriya DA, Kulatunga S, Jayawardana N & Katulanda P (2016): Computer vision syndrome among computer office workers in a developing country: an evaluation of prevalence and risk factors. BMC research notes 9: 150.
32. Rolando M, Barabino S, Mingari C, Moretti S, Giuffrida S & Calabria G (2005): Distribution of conjunctival HLA-DR expression and the pathogenesis of damage in early dry eyes. Cornea 24: 951–954.
33. Sapkota K, Franco S, Sampaio P & Lira M (2016): Effect of three months of soft contact lens wear on conjunctival cytology. Clinical & experimental optometry 99: 336–341.
34. Schnebelen C, Fourgeux C, Pasquis B, Creuzot-Garcher CP, Bron AM, Bretillon L & Acar N (2011): Dietary polyunsaturated fatty acids reduce retinal stress induced by an elevation of intraocular pressure in rats. Nutrition research (New York, NY) 31: 286–295.
35. Sengor T, Aydin Kurna S, Ozbay N, Ertek S, Aki S & Altun A (2012): Contact lens-related dry eye and ocular surface changes with mapping technique in long-term soft silicone hydrogel contact lens wearers. Eur J Ophthalmol 22(Suppl 7): S17–S23.
36. Sheppard J, Singh R, McClellan A, et al. (2013): Long-term supplementation with n-6 and n-3 PUFAs improves moderate-to-severe keratoconjunctivitis sicca: A randomized double-blind clinical trial. Cornea 32: 1297–1304.
37. Simon E, Bardet B, Gregoire S, Acar N, Bron AM, Creuzot-Garcher CP & Bretillon L (2011): Decreasing dietary linoleic acid promotes long chain omega-3 fatty acid incorporation into rat retina and modifies gene expression. Exp Eye Res 93: 628–635.
38. Tauste Francés A, Ronda-Pérez E & Seguí Crespo M (2014): Alteraciones oculares y visuales en personas que trabajan con ordenador y son usuarias de lentes de contacto: una revisión bibliográfica. Rev Esp Salud Pública 88: 203–2015.
39. Tsubota K, Fukagawa K, Fujihara T, Shimmura S, Saito I, Saito K & Takeuchi T (1999): Regulation of human leukocyte antigen expression in human conjunctival epithelium. Invest Ophthalmol Vis Sci 40: 28–34.
40. Vehof J, Kozareva D, Hysi PG & Hammond CJ (2014): Prevalence and risk factors of dry eye disease in a British female cohort. The British journal of ophthalmology 98: 1712–1717.
41. Viau S, Maire MA, Pasquis B, et al. (2009): Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 247: 1039–1050.
42. Villani E, Ceresara G, Beretta S, Magnani F, Viola F & Ratiglia R (2011): In vivo confocal microscopy of meibomian glands in contact lens wearers. Invest Ophthalmol Vis Sci 52: 5215–5219.
43. Walter SD, Gronert K, McClellan AL, Levitt RC, Sarantopoulos KD & Galor A (2016): Omega-3 Tear Film Lipids Correlate With Clinical Measures of Dry Eye. Invest Ophthalmol Vis Sci 57: 2472–2478.
44. Wojtowicz JC, Butovich I, Uchiyama E, Aronowicz J, Agee S & McCulley JP (2011): Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye. Cornea 30: 308–314.